Baudax Bio, Inc.

BXRX · NASDAQ
Analyze with AI
9/30/2023
6/30/2023
3/31/2023
12/31/2022
Operating Activities
Net Income-$2-$7-$7-$9
Dep. & Amort.$0$0$0$0
Deferred Tax-$4$3$0$0
Stock-Based Comp.$0$0$0$0
Change in WC$3$1$1-$1
Other Non-Cash-$0$0$2$6
Operating Cash Flow-$2-$3-$5-$4
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$0$0$0$0
Investing Cash Flow-$0$0$0$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$2$0$0$4
Stock Repurch.$0$0-$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$1$1$3$3
Financing Cash Flow$1$1$3$3
Forex Effect$0$0$0-$0
Net Chg. in Cash-$1-$2-$1-$0
Supplemental Information
Beg. Cash$1$4$5$6
End Cash$0$1$4$5
Free Cash Flow-$2-$3-$5-$4
Baudax Bio, Inc. (BXRX) Financial Statements & Key Stats | AlphaPilot